Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of the Efficacy of AT1001 (Larazotide Acetate) to Treat Celiac Disease

This study has been completed.
Information provided by (Responsible Party):
Alba Therapeutics Identifier:
First received: April 27, 2009
Last updated: July 12, 2012
Last verified: January 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2010
  Primary Completion Date: November 2009 (Final data collection date for primary outcome measure)